| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
17,391 |
13,858 |
$1.51M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
13,940 |
10,772 |
$822K |
| 99199 |
Unlisted special service, procedure or report |
97,517 |
52,922 |
$449K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
9,249 |
7,693 |
$391K |
| 99215 |
Prolong outpt/office vis |
3,123 |
2,582 |
$358K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,893 |
2,399 |
$262K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,058 |
1,662 |
$177K |
| 99050 |
|
7,270 |
6,155 |
$174K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,877 |
1,544 |
$168K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
5,918 |
5,076 |
$55K |
| 96127 |
|
9,680 |
7,920 |
$54K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,488 |
1,133 |
$47K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,624 |
3,132 |
$46K |
| D0145 |
Oral evaluation for a patient under three years of age |
1,104 |
922 |
$37K |
| 87428 |
|
715 |
480 |
$33K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
324 |
257 |
$32K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
698 |
598 |
$17K |
| D1206 |
Topical application of fluoride varnish |
1,099 |
919 |
$16K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
428 |
364 |
$15K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
832 |
658 |
$14K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
83 |
65 |
$10K |
| 80061 |
Lipid panel |
440 |
368 |
$7K |
| 0240U |
|
51 |
28 |
$5K |
| 92551 |
|
6,481 |
5,464 |
$4K |
| 99058 |
|
202 |
182 |
$3K |
| 81003 |
|
1,226 |
935 |
$2K |
| 87807 |
|
191 |
136 |
$2K |
| 85018 |
|
4,253 |
3,515 |
$2K |
| 96161 |
|
595 |
519 |
$2K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
87 |
54 |
$2K |
| 90686 |
|
4,218 |
3,327 |
$2K |
| 99173 |
|
6,806 |
5,749 |
$1K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
578 |
372 |
$1K |
| 90473 |
|
71 |
59 |
$981.60 |
| 69210 |
|
31 |
24 |
$790.24 |
| 94664 |
|
84 |
76 |
$756.84 |
| 90633 |
|
140 |
108 |
$104.00 |
| 83655 |
|
239 |
212 |
$89.58 |
| 36416 |
|
5,090 |
4,284 |
$61.16 |
| 94760 |
|
2,066 |
1,865 |
$10.75 |
| 99000 |
|
1,831 |
1,701 |
$0.00 |
| 90674 |
|
665 |
559 |
$0.00 |
| 90680 |
|
251 |
199 |
$0.00 |
| 90744 |
|
132 |
89 |
$0.00 |
| 90698 |
|
448 |
352 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
63 |
52 |
$0.00 |
| 90716 |
|
87 |
70 |
$0.00 |
| 90651 |
|
102 |
68 |
$0.00 |
| 90677 |
|
14 |
14 |
$0.00 |
| 90707 |
|
73 |
56 |
$0.00 |
| 90670 |
|
895 |
757 |
$0.00 |
| 90672 |
|
107 |
81 |
$0.00 |